Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


About our content


Access leading, evidence-based scientific and market information on drugs in commercial development worldwide. Drug and cell-based products are tracked across all therapeutic areas and throughout the entire development process, from discovery to launch.

Profiles include:

  • Key development milestones
  • Development status and history
  • Drug properties
  • Chemical synopses
  • Pharmacokinetics data
  • Pharmacodynamics data
  • Company agreements
  • Trial landscape and details
  • Related safety reports
  • Patent information
  • Related drugs
  • Drug limitations
  • Immunogenicity


Quickly identify the clinical trials being performed to advance these drugs through international regulatory pathways, with coverage of both international and observational trials.

Profiles include:

  • Phase of trial and current status
  • Trial purpose, focus and design
  • Primary and other endpoints
  • Diseases and subjects treated
  • Inclusion and exclusion criteria
  • Trial identifiers
  • Organizations involved
  • Initiation, completion and end dates
  • Interventions
  • Study center and investigator details
  • Trial history
  • Outcomes and results
  • Related authors

Safety Reports

The most comprehensive and reliable worldwide resource for pharmacovigilance literature monitoring, AdisInsight provides fast and easy access to published adverse drug reaction (ADR) case reports, drug safety studies and regulatory news covering all drugs and therapeutic areas, updated daily.

Records provide:

  • Easy identification of serious, overdose, interaction and first published case reports
  • Expert summaries of Individual Case Safety Reports (ICSRs) that comply with CIOMS II guidelines for Periodic Safety Update Reports (PSURs)
  • WHO contextual adverse event data for first published case reports
  • Full citation details with links to the full-text where available, to support further research
  • Reports dating back to 1982


Review concise summaries of purchases and acquisitions, joint ventures, and agreements for licensing, R&D, development, manufacturing, distribution and marketing with deal values given, where available. AdisInsight can help you to keep up with the ever-changing landscape of drug development, to identify opportunities for investment, business development and collaboration, and benchmark relative deal values and terms for your own technologies.

Profiles include:

  • Type of agreement
  • Date of agreement
  • Organizations involved
  • Drugs involved
  • Indications involved
  • Summary of the deal
  • Deal value


Patents is an extension of Drugs providing key information about the global parents and market exclusivities protecting a specific drug. For an AdisInsight Drug profile there is a corresponding Drug Patent Profile that presents the global patents and market exclusivities that are protecting that drug. Patent information is presented in summary tables to facilitate quick and easy understanding of key patent information impacting a drug landscape and determining the timing of generic entry.

  • Drug name
  • Country
  • Patent number
  • Claim type
  • Patent title
  • Filing date
  • Loss of patent date
  • Brand name
  • BLA / NDA / ANDA
  • Patent applicant
  • Source
Back to top